This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Kaithamana Shashi: Innovator in Insulin Preparation
Introduction
Kaithamana Shashi is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the preparation of insulin. His innovative approach has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.
Latest Patents
Kaithamana Shashi holds a patent for a method of preparing insulin by cleavage of a fusion protein. The patent describes a protein precursor of a double-chain molecule that consists of at least two polypeptide chains linked by two disulfide bonds. The precursor has the general formula B—Z—A, where B and A represent the two insulin polypeptide chains, and Z is a polypeptide that includes at least one site for proteolytic cleavage. This method allows for the production of a secreted double-chain product consisting of disulfide-bonded A and B chains, facilitating the isolation of mature insulin.
Career Highlights
Throughout his career, Kaithamana Shashi has focused on advancing biotechnological methods for insulin production. His work has been instrumental in developing more effective processes that can be utilized in eukaryotic host cells. This innovation not only improves the yield of insulin but also enhances the purification process, making it more efficient.
Collaborations
Kaithamana Shashi has collaborated with notable professionals in his field, including Candadai Seshardi Ramadoss and Christopher Hadfield. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Kaithamana Shashi's contributions to insulin preparation through innovative methods highlight his role as a significant inventor in the biotechnology sector. His work continues to impact the field positively, paving the way for advancements in diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile